Skip to main content
D

Digostics

Digostics has created a glucose tolerance testing platform that allows users to perform at-home tests with an easy-to-use device, providing real-time data on glucose metabolism. This technology enables early identification of potential metabolic disorders, improving health monitoring and management for individuals.

Founded 201914300+ followers
Updated 4 months ago

Funding

$673.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional in-clinic Oral Glucose Tolerance Tests (OGTT) for diabetes screening can be inconvenient and resource-intensive, leading to challenges in patient access, staffing requirements, and risks of sample degradation due to laboratory delays. This can result in delayed diagnoses and missed opportunities for early clinical intervention.

Solution

Digostics offers GTT@home, a remote diagnostic solution that enables patients to perform lab-quality OGTTs from the comfort of their homes. The GTT@home kit includes a test device, a preformulated glucose drink, finger prickers, a user guide, and a prepaid return envelope. The test device measures glucose levels in capillary blood samples and uses Near Field Communication (NFC) to transmit data to the patient's care team via a mobile app. This eliminates the need for clinic visits, reduces administrative burden, and mitigates the risk of sample degradation, providing accurate and timely results for diabetes detection. Digostics also provides a secure, HL7 FHIR-compliant web portal for healthcare professionals to schedule tests and review results.

Target Audience

Digostics primarily targets healthcare providers, hospitals, and clinical researchers seeking to improve diabetes screening accessibility, increase patient throughput, and reduce the costs associated with traditional in-clinic OGTTs.

Features

  • Complete home test kit including all necessary materials for remote OGTT
  • GTT@home test device with two glucose test sensors for fasting and two-hour measurements
  • Onboard timer to ensure accurate interval between tests
  • NFC functionality for immediate data transmission via mobile app
  • Option for postal return of test data
  • Digostics Portal for healthcare professionals to schedule tests and review results
  • HL7 FHIR compliance for seamless interoperability with hospital systems
  • Customer support available 7 days a week
This profile is AI-generated and may contain inaccuracies.